7 completed, 3 terminated, 2 withdrawn, 1 not yet recruiting. 13 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 7, Terminated 3, Withdrawn 2, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Diastolic Heart Failure: new trials by email Literature Review of Diastolic Heart Failure trials Research Report on Diastolic Heart Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Bimagrumab in Participants With HFpEF Bimagrumab, Placebo - Heart Failure, Diastolic, Diastolic Heart Failure | Phase 2 | Not yet recruiting | Eli Lilly and Company | 540 | 2026-11-01 | 2026-11-06 |
| Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES Sulforaphane - Diastolic Dysfunction, Systolic Dysfunction | Phase 1 / Phase 2 | Withdrawn | Texas Tech University Health Sciences Center | 2022-07-01 | 2026-06-29 | |
| Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF KNO3, KCl - Heart Failure, Diastolic Heart Failure | Phase 2 | Completed | University of Pennsylvania | 12 | 2015-01-01 | 2017-10-03 |
| If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure Ivabradine, Placebo - Diastolic Heart Failure | Phase 2 | Withdrawn | St Vincent's University Hospital, Ireland | 2012-12-01 | 2014-11-25 | |
| Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction renal denervation - Diastolic Heart Failure, Hypertension | Phase 2 / Phase 3 | Terminated | UMC Utrecht | 60 | 2012-04-01 | 2021-05-03 |
| Ranolazine in Diastolic Heart Failure Ranolazine, Saline 0.9% and placebo tablet - Diastolic Heart Failure | Phase 2 | Completed | Gilead Sciences | 20 | 2010-04-01 | 2012-07-12 |
| Metoprolol XR in Heart Failure With Normal Ejection Fraction Metoprolol XR - Diastolic Heart Failure | Phase 2 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 102 | 2010-01-01 | 2019-03-21 |
| Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome Perhexiline, Placebo - Diastolic Heart Failure | Phase 2 | Completed | University of Aberdeen | 70 | 2009-03-01 | 2015-11-05 |
| Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I) alagebrium, placebo - Diastolic Heart Failure | Phase 2 | Terminated | Synvista Therapeutics, Inc | 160 | 2008-03-01 | 2009-01-30 |
| A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure Alagebrium - Diastolic Heart Failure | Phase 2 | Terminated | Cardiovascular Clinical Sciences Inc | 134 | 2007-12-01 | 2013-08-01 |
| A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure Sitexsentin sodium, Placebo - Diastolic Heart Failure | Phase 2 | Completed | Pfizer | 200 | 2006-03-27 | 2023-01-04 |
| Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure Sildenafil, Placebo - Pulmonary Hypertension, Diastolic Heart Failure | Phase 2 / Phase 3 | Completed | University of Milan | 44 | 2006-01-01 | 2012-06-15 |
| Study of Nesiritide in Diastolic Heart Failure. neseritide - Diastolic Heart Failure | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 20 | 2002-12-01 | 2014-03-26 |
Heart Failure, Diastolic (13) · Heart Failure (3) · Coronary Artery Disease (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Sarcopenia (1)
Cardiovascular Diseases (13) · Heart Diseases (13) · Heart Failure (10) · Vascular Diseases (3) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atrophy (1) · Coronary Disease (1) · Hypertension (1) · Lung Diseases (1) · Muscular Atrophy (1) · Myocardial Ischemia (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1)
alagebrium (2) · Ivabradine (1) · Perhexiline (1) · Potassium Chloride (1) · Ranolazine (1) · Saline Solution (1) · Sildenafil Citrate (1) · Sodium Chloride (1) · bimagrumab (1) · potassium nitrate (1) · sulforaphane (1)
Cardiovascular Clinical Sciences Inc (1) · Eli Lilly and Company (1) · Gilead Sciences (1) · Massachusetts General Hospital (1) · Pfizer (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · St Vincent's University Hospital, Ireland (1) · Synvista Therapeutics, Inc (1) · Texas Tech University Health Sciences Center (1) · UMC Utrecht (1) · University of Aberdeen (1) · University of Milan (1) · University of Pennsylvania (1)
United States (5) · Canada (1) · Germany (1) · Hungary (1) · India (1) · Ireland (1) · Italy (1) · Netherlands (1) · Poland (1) · United Kingdom (1)
Bertram Pitt, MD (1) · Dermot J McCaffrey, MB MRCPI FRACP (1) · Julio A Chirinos, MD (1) · Lars S. Maier, MD (1) · Marc J S, MD (1) · Michael P Frenneaux, MBBS MD (1) · Michiel Voskuil, MD, PhD (1) · Samir Malhotra, MD, DM (1)
PMID 21538388, PMID 21709061, PMID 23883653, PMID 24621836, PMID 24720918, PMID 25495811, PMID 27927683